For a 90 kg patient with type 2 diabetes on prednisone 15 mg daily and insulin glargine (Lantus) 12 U, with an insulin‑to‑carbohydrate ratio of 1 unit per 6 g carbs and insulin sensitivity factor 35, experiencing post‑meal hyperglycemia, should I increase the insulin‑to‑carbohydrate ratio rather than add NPH insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Increase Your Insulin-to-Carbohydrate Ratio (ICR)

You should tighten your insulin-to-carbohydrate ratio rather than add NPH insulin. Your patient is experiencing persistent postprandial hyperglycemia despite correction doses, indicating inadequate prandial insulin coverage for the carbohydrate intake—not insufficient basal insulin coverage.

Why Adjust ICR, Not Add NPH

The Blood Glucose Pattern Tells the Story

Your patient's glucose trajectory reveals the problem:

  • Fasting BG 155 mg/dL at 8 AM: Slightly elevated but not severely uncontrolled
  • BG 243 mg/dL at noon (2 hours post-151g carbs): Massive postprandial spike
  • BG 210 mg/dL at 5 PM despite correction: Still elevated from inadequate meal coverage
  • BG 144 mg/dL at 9 PM and 103 mg/dL at 1 AM: Trending down appropriately

This pattern demonstrates inadequate prandial insulin coverage, not basal insulin failure. The basal insulin (Lantus 12 units) is working—evidenced by the overnight glucose dropping from 144 to 103 mg/dL without hypoglycemia.

The Prednisone Factor

Prednisone 15 mg daily at 8 AM creates peak hyperglycemic effects from late morning through evening 1, 2. The 2025 ADA Standards specifically note: "Consider dosing NPH in the morning for steroid-induced hyperglycemia" 1. However, your patient is already on basal insulin (Lantus), and the problem is clearly postprandial, not basal.

The 2022 systematic review on glucocorticoid-induced hyperglycemia confirms that steroid-induced hyperglycemia predominantly affects postprandial glucose 2. Your patient's pattern—normal overnight glucose but massive postprandial spikes—fits this perfectly.

Specific Recommendations

1. Tighten the ICR Immediately

Current ICR: 1:6 (1 unit per 6g carbs)

Recommended new ICR: 1:4 to 1:5 (1 unit per 4-5g carbs)

Calculation rationale:

  • At 10 AM: 151g carbs ÷ 6 = 25 units given (implied)
  • BG rose from 155 to 243 mg/dL = 88 mg/dL increase
  • At noon: 102g carbs ÷ 6 = 17 units + 3 units correction = 20 units total
  • BG only dropped from 243 to 210 by 5 PM = inadequate coverage

Start with ICR 1:5, which would provide:

  • 151g ÷ 5 = 30 units (5 more units than current)
  • 102g ÷ 5 = 20 units (3 more units than current)

This 15-30% increase in prandial insulin aligns with the 2025 ADA guideline recommendation to "increase dose by 1-2 units or 10-15% twice weekly" 1.

2. Maintain Current Basal Insulin

Keep Lantus at 12 units once daily. The overnight glucose control (144 → 103 mg/dL) demonstrates adequate basal coverage. The fasting BG of 155 mg/dL is only modestly elevated and will improve once postprandial control is achieved.

3. Adjust ISF if Needed

Your current ISF of 1:35 (1 unit lowers BG by 35 mg/dL) may also need tightening given the prednisone. The 3-unit correction at noon should have lowered BG by 105 mg/dL, but it only dropped 33 mg/dL by 5 PM (though meal insulin was also given).

Consider ISF 1:30 if correction doses continue to be inadequate after ICR adjustment.

Why NOT Add NPH

NPH Would Create Problems, Not Solutions

  1. Timing mismatch: NPH given in the morning peaks 4-12 hours later 1, which would overlap with your patient's evening meal and create nocturnal hypoglycemia risk—your patient already has good overnight control (103 mg/dL at 1 AM).

  2. Redundant basal coverage: Adding NPH to existing Lantus creates overlapping basal insulin without addressing the core problem of inadequate prandial coverage 1.

  3. Increased complexity: The 2025 ADA guidelines recommend NPH for steroid-induced hyperglycemia primarily when initiating insulin therapy, not when already on a basal-bolus regimen 1. Your patient already has basal coverage.

  4. Guidelines support prandial intensification first: The 2025 ADA algorithm clearly states: "If A1C remains above goal: Initiation and titration of prandial insulin... Usually one dose with the largest meal or meal with greatest PPG excursion" 1. Your patient needs more prandial insulin, not different basal insulin.

Monitoring and Titration

Immediate Actions (Next 3 Days)

  • Change ICR to 1:5 for all meals
  • Monitor pre-meal and 2-hour post-meal glucose
  • Watch for hypoglycemia, especially overnight (though unlikely given current pattern)

Reassess in 3-7 Days

  • If 2-hour postprandial BG remains >180 mg/dL: Tighten ICR to 1:4
  • If fasting BG remains >130 mg/dL after postprandial control achieved: Increase Lantus by 2 units 1
  • If hypoglycemia occurs: Loosen ICR back to 1:5.5 or reduce by 10-20% 1

Common Pitfalls to Avoid

  1. Don't add NPH "just because" of prednisone: The steroid effect is already being addressed by your basal-bolus regimen; you just need more prandial insulin.

  2. Don't undertitrate prandial insulin: The 2026 research on dexamethasone-induced hyperglycemia found that "current practice underdoses insulin glargine initially for DIH management and relies on reactive bolus insulin with limited success" 3. Be aggressive with prandial insulin adjustments.

  3. Don't ignore the carbohydrate load: 151g carbs at one meal is substantial. Consider discussing carbohydrate distribution with the patient—spreading intake more evenly may improve control.

  4. Don't wait too long to adjust: The 2025 ADA guidelines emphasize avoiding therapeutic inertia: "reassess and modify regularly (3-6 months)" 1. With steroid-induced hyperglycemia, adjust every 3-7 days until controlled.

The Bottom Line

Your patient's glucose pattern screams inadequate prandial insulin coverage, not basal insulin failure. The prednisone is amplifying postprandial hyperglycemia, which requires more aggressive prandial insulin dosing through a tighter ICR (1:5 or 1:4), not the addition of NPH insulin. The current basal insulin (Lantus 12 units) is working appropriately as evidenced by stable overnight glucose. Adjust the ICR first, monitor closely, and titrate aggressively 1, 2, 3.

References

2
Guideline

glucocorticoid-induced hyperglycemia including dexamethasone-associated hyperglycemia in covid-19 infection: a systematic review.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Related Questions

For a 66‑year‑old male with type 2 diabetes, weight 84 kg, NPO during the day and receiving tube feeds from 1600 to 0800, on insulin glargine (Lantus) 22 units at 1700 and prednisone 20 mg at 0800, with an insulin‑sensitivity factor of 15 mg/dL at 1600 and 2000, and blood glucose of 199 mg/dL at 1600 and 244 mg/dL at 2000, what fixed dose of rapid‑acting insulin aspart (Novolog) should be administered at 1600 and what dose of intermediate‑acting insulin (NPH) should be given at 2000?
In a 58-year-old female weighing 98.8 kg with normal renal function who was taking prednisone 15 mg and insulin (15 U NPH insulin at 8 am, insulin‑to‑carbohydrate ratio 1 U per 5 g carbs, insulin sensitivity factor 15 mg/dL per unit, and 50 U insulin glargine), what insulin glargine dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio should be used today when prednisone is omitted?
For a 27‑year‑old female on dexamethasone 20 mg daily who is currently taking 52 U of NPH insulin (Neutral Protamine Hagedorn) at 08:00 and using an insulin‑to‑carbohydrate ratio (ICR) of 3 g per unit (insulin sensitivity factor 15 mg/dL), with blood glucose readings of 213 mg/dL at 08:00, 269 mg/dL at 13:00, 96 mg/dL at 15:00, 278 mg/dL at 22:00, and 285 mg/dL at 01:00, what should the 08:00 NPH dose be, what should the ICR be, and what dose of NPH insulin should be added at 20:00?
For a 21‑year‑old female weighing 79.3 kg with type 2 diabetes who takes methylprednisolone 1000 mg at 11 am together with NPH insulin (neutral protamine Hagedorn) 70 U (insulin‑to‑carbohydrate ratio 3 g/unit, insulin sensitivity factor 10 mg/dL per unit) and insulin glargine (Lantus) 20 U at 8 pm, with blood glucose readings of 383 mg/dL at 1 pm after eating 48 g carbohydrate, 344 mg/dL at 4 pm, 286 mg/dL at 6 pm, 272 mg/dL at 8 pm, and 221 mg/dL at 10 pm, what should the NPH insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
In a 42‑year‑old male with type 2 diabetes, weight 156 kg, creatinine 2.43 mg/dL, eGFR 33 mL/min, who received prednisone 40 mg at 8 am and NPH (neutral protamine Hagedorn) insulin 10 U (insulin‑to‑carbohydrate ratio 8, insulin sensitivity factor 25) with blood glucose 208 mg/dL at 8 am after 80 g carbohydrate, 249 mg/dL at 12 pm after 104 g carbohydrate, and 245 mg/dL at 6 pm, and who now has received prednisone 40 mg and methylprednisolone 62.5 mg at 11 am plus NPH 10 U at 8 am, what insulin adjustments should be made?
What neuromuscular manifestations are associated with hyperparathyroidism and what is the recommended management?
What surveillance is required for an adult patient whose estimated 10‑year cardiovascular disease risk exceeds 15%?
What percentage of patients with an acute myocardial infarction present with isolated abdominal pain and vomiting without chest pain?
What is the recommended management for constipation associated with gut‑brain axis dysfunction?
Which drugs can cause drug‑induced parkinsonism or aggravate subclinical parkinsonism, and which of these have a dose‑dependent risk versus risk at any dose?
What are the differential diagnoses of parkinsonism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.